A rare cause of haemolytic anaemia: paroxysmal nocturnal haemoglobinuria in an elderly patient by Ruiter, E.D. de et al.
A B S T R A C T
Paroxysmal nocturnal haemoglobinuria (PNH) is an
acquired haemopoietic stem cell disorder characterised
clinically by chronic haemolytic anaemia with acute
episodes, thrombosis and bone marrow failure. It is a rare
condition, which usually occurs in younger people.
Immunophenotyping and flow cytometry play a key role
in diagnosing PNH. Treatment is mainly supportive.
Because it is so rare, delay in diagnosis is not uncommon
in patients with PNH, which has a considerable impact
on patient management and prognosis.
We present this case to draw attention to this rare cause of
haemolytic anaemia, which should be considered in any
patient, of any age, who has signs of chronic haemolysis.
I N T R O D U C T I O N
Paroxysmal nocturnal haemoglobinuria, also known as the
Marchiafava-Micheli syndrome, is an uncommon acquired
clonal disorder characterised by chronic haemolysis with
acute exacerbations, cytopenias of varying extent and a
tendency to venous thrombosis.1-3 It is associated with a
somatic mutation in the PIG-A gene of a totipotent
haemopoietic stem cell causing the blood cells of the PNH
clone to be deficient in glycosyl phosphatidyl inositol
anchored membrane proteins. Deficiency of these proteins
leads to an increased sensitivity of PNH cells to complement-
mediated lysis, which is responsible for chronic intravascular
haemolysis and probably also for thrombosis.3-5 The
haemolysis usually occurs at night, although not in all
patients. The reasons for this nightly occurrence are unclear
but a lowering of blood pH at night may play a role.
There is a close relation to aplastic anaemia and PNH
may convert into acute leukaemia.6-8 PNH usually occurs
in young adults. In the present case, we report a Caucasian
woman of older age with haemolytic anaemia in whom
PNH was diagnosed.
C A S E  R E P O R T
A 67-year-old Caucasian woman presented with a history
of progressive fatigue, dizziness and presumed haematuria,
for which she had already seen a urologist who diagnosed
an asymptomatic urinary tract infection. Her medical
history revealed hysterectomy, angina pectoris and a
frozen shoulder. Her mother died of chronic leukaemia at
the age of 80. Her medication consisted of nitrofurantoin,
ramipril and celiprolol. Physical examination showed a
pale, tired-looking woman with normal blood pressure,
pulse and temperature. No pathological lymph nodes were
found. Heart, lungs and abdomen revealed no abnormalities.
She had vitiligo over the upper extremities. The ECG and
chest X-ray were both normal.
Laboratory tests showed the following results: ESR 31 mm/h
(N. 2-20), haemoglobin 5.4 mmol/l (N. 7.5-10.5), Ht 0.27 l/l
(N. 0.36-0.50), MCV 101 fl (N. 82-100), leucocytes 4.7 x 109/l
(N. 4.0-10.0), platelet count 154 x 109/l (N. 130-340),
haptoglobin <0.1 mmol/l (N. 0.28-2.00), LDH 8609 U/l
(N. <450), bilirubin 36 mol/l (N. <17), serum iron 15 mol/l
(N. 10-30) and reticulocyte count 70% (N. 0.7-2.4). Urine
analysis showed haemoglobin and haemosiderin.
Apparently, the patient was suffering from intravascular
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haemolysis. A direct Coombs’ test was negative. The blood
smear showed no spherocytes, elliptocytes or fragmentocytes.
Erythrocyte enzymes, such as G-6-PD, were normal as
was haemoglobin electrophoresis. The following step in
Coombs-negative haemolysis is the Ham’s test and sucrose
haemolysis test. Both these tests can confirm haemolysis
in red cells of a patient’s serum by activating complement,
the first by lowering serum pH and the second by reducing
ionic strength. The Ham’s test was positive in our patient. To
confirm the diagnosis, flow cytometry was then performed,
which provided immunological evidence for the existence
of PNH in our patient. This test uses monoclonal antibodies
against phosphatidyl inositol (PI) anchored proteins on
granulocytes, which under normal circumstances protect
cells against complement-mediated lysis. In PNH, expression
of these proteins is significantly reduced or absent, as in
our patient, causing lysis of red cells.
Our patient was treated with blood transfusion, and iron
and folic acid suppletion. In addition, we started with
acenocoumarol as a prophylaxis against thrombosis which,
after infections, is the main cause of death in patients with
PNH. Our patient was readmitted after six months for
another transfusion but is doing very well at the moment.
D I S C U S S I O N
We present here a case of PNH in a 67-year-old woman.
There was a delay in diagnosis because her haemoglobinuria
was first thought to be haematuria. Doctors tend to overlook
the diagnosis of PNH in patients with chronic haemolysis.
Our patient was remarkable because of her age at
presentation. Most patients diagnosed with this condition
are young adults, the main symptoms usually first
appearing in the third and fourth decades of life.9
The clinical course of PNH is highly variable, ranging
from a mild defect to a lethal process. As previously stated,
the main clinical features consist of haemoglobinuria,
episodic haemolysis, marrow hypoplasia and thrombotic
disease.1-3 Renal failure occurs rarely in PNH.10 There is a
close relation to aplastic anaemia and conversion into acute
leukaemia occurs in 5 to 15% of all patients.6-8 PNH should
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be considered a very serious disease, the complications of
which can be fatal. Nowadays, however, even mild cases
can be detected because of new techniques such as flow
cytometry, which is a specific diagnostic test for PNH.11 In
PNH, expression of PI-anchored proteins is significantly
reduced or absent due to a mutation of the PIG-A gene,
causing absence of PI-anchored proteins. In normal circum-
stances these proteins protect against complement-mediated
lysis of red cells (figure 1). Flow cytometric analysis can
exactly measure the expression of antigens on each cell
membrane and estimate the percentage of deficient cells
by using monoclonal antibodies. In our patient, only 5%
of the granulocytes reacted with CD59, CD24 and CD16
antibodies, which recognise PI-anchored proteins.
Erythrocytes of PNH patients are most deficient for DAF
(CD55), MIRL (CD59) and AchE (CLBgran/5Ag).
PNH must be differentiated from antibody-mediated
haemolytic anaemias (AIHA), especially paroxysmal cold
haemoglobinuria and the cold agglutinin syndrome. This
was done in our patient by performing a direct Coombs’
test, which was negative. Warm and cold antibodies were
also negative. Other causes of chronic haemolysis, such
as corpuscular defects, were ruled out as well. Molecular
analysis of haemoglobin showed no abnormalities.
Erythrocyte enzyme values were normal.
With the exception of bone marrow transplantation, there
is no curative therapy available.12 Treatment depends on
the clinical picture and consists of supportive measures,
such as transfusion, antibiotics and anticoagulants.1,2
Thrombosis occurs frequently and accounts for 50% of all
deaths in PNH. Beneficial effects of steroids and splenectomy
have been reported. We describe a patient with chronic
haemolytic anaemia caused by PNH, which was diagnosed
by flow cytometry. She was treated with blood transfusions,
iron and folic acid suppletion, and a prophylaxis against
thrombotic complications.
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